ORAI3 and lung carcinoma: As for ORAI channels, very recently, Ouadid-Ahidouch’s group demonstrated clearly the involvement of ORAI3 in the enrichment of the CSC population by cisplatin treatment in lung cancer cell models, which, in turn, induces resistance to cisplatin [59] (Table 3).